Compared to Estimates, Vertex (VRTX) Q2 Earnings: A Look at Key Metrics

Vertex Pharmaceuticals (VRTX) reported $2.65 billion in revenue for the quarter ended June 2024, representing a year-over-year increase of 6.1%. EPS of -$12.83 for the same period compares to $3.89 a year ago. The reported revenue compares to the Zacks Consensus Estimate of $2.65 billion, representing a surprise of -0.08%. The company delivered an EPS surprise of -11.57%, with the consensus EPS estimate being -$11.50. While investors scrutinize revenue and earnings changes year-over-year and how they compar ...